(Q39849945)

English

Dendritic cells loaded with HIV-1 p24 proteins adsorbed on surfactant-free anionic PLA nanoparticles induce enhanced cellular immune responses against HIV-1 after vaccination

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Dendritic cells loaded with HIV-1 p24 proteins adsorbed on surfactant-free anionic PLA nanoparticles induce enhanced cellular immune responses against HIV-1 after vaccination (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

Philippe Roingeard

4

object named as

Philippe Roingeard

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

author name string

Fleur Aline

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Denys Brand

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Josette Pierre

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Munier Séverine

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Bernard Verrier

6

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Isabelle Dimier-Poisson

7

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

language of work or name

0 references

publication date

29 May 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

5284-5291

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Dendritic cell-based cancer immunotherapy targeting MUC-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Therapeutic dendritic-cell vaccine for chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Therapeutic Immunization with Dendritic Cells Loaded with Heat‐Inactivated Autologous HIV‐1 in Patients with Chronic HIV‐1 Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Peptide-loaded dendritic-cell vaccination followed by treatment interruption for chronic HIV-1 infection: a phase 1 trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Generation of specific Th1 and CD8+ T-cell responses by immunization with mouse CD8+ dendritic cells loaded with HIV-1 viral lysate or envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Overexpression of HIV-1 proteins in Escherichia coli by a modified expression vector and their one-step purification.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Effect of solvent on the preparation of surfactant-free poly(DL-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

A novel CD4-CD8alpha+CD205+CD11b- murine spleen dendritic cell line: establishment, characterization and functional analysis in a model of vaccination to toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Nanoparticles target distinct dendritic cell populations according to their size

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

B cell tumor vaccine enhanced by covalent attachment of immunoglobulin to surface proteins on dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Coadsorption of HIV-1 p24 and gp120 proteins to surfactant-free anionic PLA nanoparticles preserves antigenicity and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2009.05.028

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39849945&oldid=2091478392"